Navigation Links
Hillenbrand, Inc. Reports Third-Quarter Revenue of $165 Million and Earnings Per Share of $0.42
Date:8/12/2008

BATESVILLE, Ind., Aug. 12 /PRNewswire-FirstCall/ -- Hillenbrand, Inc. (NYSE: HI) reported third-quarter 2008 revenue of $165 million, consistent with $165.6 million reported in the third quarter of 2007. In addition, the company reported growth in third-quarter earnings per share, operating profit and cash flow from operations over prior year results.

Revenue for the quarter remained essentially flat, even as the company faced some challenging headwinds from a decline in volume. This was largely due to the termination of the planned acquisition of an independent distributor last year, which resulted in the cancellation of a related supply agreement with that distributor. In addition, revenue was impacted by a general decline in burials and a lower average product mix.

"After an increase in influenza-related deaths in the second quarter, we experienced the typical seasonal slowdown in the third quarter," said Kenneth A. Camp, president and CEO of Hillenbrand, Inc. "Despite the market challenges, we were able to maintain revenues at a level consistent with 2007 results."

Gross profit remained stable, as substantial increases in fuel and commodity prices were offset by productivity cost improvements and improved material usage. Third-quarter total operating expenses were favorable by 16.7 percent to the prior year because of a $6.8 million one-time expense in 2007 related to the terminated acquisition.

The company's effective tax rate for the quarter was 34.9 percent versus 36.4 percent in the same period in 2007, reflecting the effects of an increased benefit from manufacturing tax deductions in 2008. Net income for the quarter was $26.7 million, or $0.42 fully diluted earnings per share, up from $21.5 million, or
'/>"/>

SOURCE Hillenbrand, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hillenbrand, Inc. Declares First Quarterly Dividend As a New Publicly Traded Company
2. Hillenbrand, Inc. Names Joe A. Raver President and Chief Operating Officer of Batesville Casket Company
3. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... UCW Academy of Health holds open house at Vi... BC (Vocus) November 8, 2009 -- UCW Academy of Hea...itish Columbia’s health care industry to att...ember 25, 2009. , ,UCW Academy of Health, which o...rsing and social services, designs its programs to...
(Date:11/8/2009)...nd Crushing Taxes Nail Nation,s Job Creators ,,...response to U.S. House passage of the health care ...rship Council (SBE Council) president & CEO Ka..., "Make no mistake, those voting for H.R. 3962 vot... costs and crushing taxes and penalties. Even in t...
(Date:11/8/2009)...v. 7 Tonight the House ...re for America Act, landmark health reform legisla... quality, affordable, stable and secure health car...some of the insurance industry,s worst practices, ...cut the deficit by $104 billion over ten years. Gr...
(Date:11/8/2009)... 3D Global Solutions is pleased to announce t... proposal effort for ReSound who recently received...id contract. The award includes not only the Veter...ense and other federal agencies. , ... 3D Global Solutions is pleased to announce that i...
(Date:11/8/2009)... Men’s Health Network (MHN) urges milit...pecially those linked to exposure to chemicals, at...e. Bladder cancer is one of those cancers that is ...hose who once smoked or currently smoke cigarettes... November 8, 2009 -- Men’s Health Network (M...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3
...esearch Shows the New Test is Accurate, Simple to ... Resources, BEIJING, Nov. 8 Research demonst... developed by QIAGEN with support,from PATH -- a n...e 24th International Papillomavirus Conference in,...
...xperienced Consultant and Industry Thought Leader ...nsulting Practice, SANTA ANA, Calif., Nov. 7 XRo...ointment of Ogan Gurel, M.D. as a Managing,Directo...care Management Consulting. "Dr. Gurel,s deep expe...
...ETHESDA, Md. Nov. 7 /Xinhua-PRNewswire/ -- Chindex...ent American provider of Western healthcare,servic... today announced,profitable results for the quarte...ember 30, 2007 was $32.7 million, a,23% increase o...
...ompany is recognized for its commitment to buildin...s, health with innovative fitness and nutrition ...CITY, Nov. 7 The American Heart Association,recen...and helping employees live healthier lives. Regenc...
...greement Provides Additional Financial Flexibility...loration Process, GERMANTOWN, Md., Nov. 7 Middle...armaceutical company focused on,developing and com...rgest equity shareholders, raising up to $10 milli...
... CHICAGO, Nov. 7 U.S. Environmental,Protection A...American Lung,Association of Indiana for a communi...for asthma and tobacco smoke while promoting indoo...hildren and adults,who suffer from asthma," said R...
Other Medicine News:Health News:Study Finds New Version of QIAGEN's HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment 2Health News:Study Finds New Version of QIAGEN's HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment 3Health News:Study Finds New Version of QIAGEN's HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment 4Health News:Study Finds New Version of QIAGEN's HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment 5Health News:Study Finds New Version of QIAGEN's HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment 6Health News:XRoads Solutions Group Appoints Dr. Ogan Gurel as Managing Director 2Health News:Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007 2Health News:Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007 3Health News:Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007 4Health News:Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007 5Health News:Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007 6Health News:Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007 7Health News:Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007 8Health News:Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007 9Health News:American Heart Association Honors Regence BlueCross BlueShield of Utah as the State's First Start! Fit-Friendly Company 2Health News:American Heart Association Honors Regence BlueCross BlueShield of Utah as the State's First Start! Fit-Friendly Company 3Health News:MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management 2Health News:MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management 3Health News:MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management 4Health News:MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management 5Health News:EPA Awards Grant to American Lung Association of Indiana for Community Environmental Health Initiative 2
(Date:11/6/2009)...Call/ -- Boston Scientific Corporation (NYSE: BSX...t in principle with the U.S. Department of Justice... Guidant subsidiary in 2005. The alleged conduct ...fic,s 2006 acquisition of Guidant. ,, Boston Sc... by the U.S. Attorney,s Office in Minneapolis into...
(Date:11/6/2009)...- Philips Respironics applauds the efforts of the ...o raise awareness about an important public health...elease of the first-ever government study to monit...a milestone in quantifying the size and scope of t...ry leader and sleep therapy manufacturer, Philips ...
(Date:11/6/2009).../ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), a b... small-molecule therapeutics for the treatment of ...), today reported recent accomplishments and finan... ended September 30, 2009. ,, (Logo: http://...,, "Since our last quarterly update, we have co...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Professor Bruce Beutler Joins aTyr Pharmas Scientific Advisory Board 53453 1Professor Bruce Beutler Joins aTyr Pharmas Scientific Advisory Board 53453 2OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results 13322 1Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 1Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 2Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 3Sports Icons Troy Aikman Clyde Drexler Mike Piazza Ivan Lendl and Dara Torres are Among the Elite Named 2009 Great Sports Legends 53448 4
...SOUTH SAN FRANCISCO, Calif. and ALLSCHWIL, Switzer...today that data,published in The Lancet(1) show th...tension (PAH) patients (WHO functional class II - ...al deterioration by significantly,delaying time to...ents,worsening to WHO FC III/IV. A significant red...
...SYDNEY, Australia, June 19 /Xinhua-PRNewswire-Firs... announced that the company and the U.S. Food,and ...n the phase 3,registration trial of Bronchitol for...t process., The SPA process allows for FDA evalua... the primary basis of an efficacy claim in support...
Other Medicine Technology:Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 2Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 3Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 4Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 5Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 6Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 2Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 3
...seats and large backrests with lumbar support &bul... and casters and glides. • Choose the BE Seri...s including: industry, education, laboratory, clea...ull; With cast aluminum base • unit standard ...
...seats and large backrests with lumbar support &bul... and casters and glides. • Choose the BE Seri...s including: industry, education, laboratory, clea...ull; With cast aluminum base • unit standard ...
BEC/1Q-ERB - Cast Aluminum Base - Model 1Q72-ERB
BET/1P-ERB - Tubular Base - Model 1P63
Medicine Products: